These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18079302)

  • 1. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.
    Léger JM; Viala K; Cancalon F; Maisonobe T; Gruwez B; Waegemans T; Bouche P
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):93-6. PubMed ID: 18079302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin].
    Delmont E; Azulay JP; Uzenot D; Attarian S; Verschueren A; Pouget J
    Rev Neurol (Paris); 2007 Jan; 163(1):82-8. PubMed ID: 17304176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy.
    Nobile-Orazio E; Cocito D; Briani C; Plasmati R; Schenone A; Gallia F; Marjanovic I; Suffredini AL
    Neurol Sci; 2017 May; 38(5):899-902. PubMed ID: 28144763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.
    Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multifocal motor neuropathies with conduction block: long-term follow-up of ten patients treated with IVIg].
    Cros D; Drake K
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S46-3S50. PubMed ID: 17075525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg.
    Vucic S; Black KR; Chong PS; Cros D
    Neurology; 2004 Oct; 63(7):1264-9. PubMed ID: 15477549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.
    Léger JM; Chassande B; Musset L; Meininger V; Bouche P; Baumann N
    Brain; 2001 Jan; 124(Pt 1):145-53. PubMed ID: 11133794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow up of multifocal motor neuropathy with conduction block under treatment.
    Azulay JP; Rihet P; Pouget J; Cador F; Blin O; Boucraut J; Serratrice G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):391-4. PubMed ID: 9120457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment.
    Slee M; Selvan A; Donaghy M
    Neurology; 2007 Oct; 69(17):1680-7. PubMed ID: 17954783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.
    Van den Berg-Vos RM; Franssen H; Wokke JH; Van den Berg LH
    Brain; 2002 Aug; 125(Pt 8):1875-86. PubMed ID: 12135977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the short-term effect of intravenous immunoglobulins in multifocal motor neuropathy using motor unit number index.
    Philibert M; Grapperon AM; Delmont E; Attarian S
    Clin Neurophysiol; 2017 Jan; 128(1):235-240. PubMed ID: 27988478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
    Gentile L; Russo M; Rodolico C; Arimatea I; Vita G; Toscano A; Mazzeo A
    Sci Rep; 2021 Apr; 11(1):9216. PubMed ID: 33911162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
    Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
    J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.
    Nobile-Orazio E; Cappellari A; Meucci N; Carpo M; Terenghi F; Bersano A; Priori A; Barbieri S; Scarlato G
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):761-6. PubMed ID: 12023421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.
    Kuwabara S; Misawa S; Mori M; Iwai Y; Ochi K; Suzuki H; Nodera H; Tamaoka A; Iijima M; Toda T; Yoshikawa H; Kanda T; Sakamoto K; Kusunoki S; Sobue G; Kaji R;
    J Peripher Nerv Syst; 2018 Jun; 23(2):115-119. PubMed ID: 29635876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
    Chaudhry V; Cornblath DR
    J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab].
    Michaud A; Delmont E; Jeandel PY; Desnuelle C
    Rev Neurol (Paris); 2011 Dec; 167(12):916-20. PubMed ID: 21752414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.